The American Journal of Psychiatry

Committed to keeping the field of psychiatry vibrant and relevant by publishing the latest advances in the diagnosis and treatment of mental illness, The American Journal of Psychiatry (AJP) is one of the most widely read psychiatric journals in the world and is the journal that the overwhelming majority of psychiatrists considers essential. Published monthly, it is an indispensable journal for all psychiatrists and other mental health professionals who need to stay on the cutting edge of virtually every aspect of psychiatry.

Highlights:

• The American Journal of Psychiatry’s latest Impact Factor is 13.391. (Clarivate Analytics, 2018)
  
• AJP is number three in psychiatry in terms of immediacy according to Thomson Scientific’s Immediacy Index. This important performance metric is a good measure of how quickly a given journal’s articles are cited—AJP’s placement is a result of publishing articles that are relevant, covering current “hot” topics and cutting-edge research, and getting these findings to the field faster with AJP in Advance, the Journal’s online-ahead-of-print publication protocol.
  
• A recent poll conducted by the BioMedical & Life Sciences Division of The Special Libraries Association identified the 100 most influential journals in all of Biology & Medicine over the last 100 years. The American Journal of Psychiatry was among those honored, the only psychiatry/psychology journal represented.

Features:

• AJP in Advance—As part of the Journal’s commitment to bringing the latest research to the field faster, all research articles now appear online in advance of their appearance in a print issue. AJP in Advance is updated with new articles on the 1st and 15th of each month (or the next business day).
  
• Treatment in Psychiatry Series—Leading experts provide a hypothetical case vignette on commonly encountered issues in patient care followed by a summary of the relevant research literature, plus offers recommendations of how to proceed with assessment and treatment.
  
• Clinical Case Conference Series— Complements the Treatment in Psychiatry series by giving additional practice oriented guidance by presenting actual patients (with disguised identities) who pose especially difficult or unique problems in diagnosis and treatment.
  
• AJP Audio—Each online issue includes a 30-minute downloadable MP3 format program that contains highlights and selected findings from the issue.
  
• Residents Journal—Each online issue is also accompanied by a FREE electronic publication produced specifically for psychiatry residents that features instructive cases, perspectives on training and career development, and discussions of unique clinical or educational programs along with special instructional columns from AJP Editors.

No other psychiatric journal reaches more psychiatrists with greater impact or immediacy than The American Journal of Psychiatry, the journal that the overwhelming majority of psychiatrists consider essential. The findings presented in AJP explore the full spectrum of issues related to mental health diagnoses and treatment, with editorials that place the most groundbreaking research into clinical context.

To visit the American Journal of Psychiatry online, please visit http://ajp.psychiatryonline.org

Highlights from the April issue of American Journal of Psychiatry:

The April issue of The American Journal of Psychiatry discusses comprehensive community care for first-episode psychosis, identification of distinct psychosis biotypes, evidence-based treatment of young people whose psychotic symptoms have not yet reached full diagnostic criteria for a psychotic disorder, and how increased and decreased appetite in depression compare in terms of neurocircuitry. Two trials of treatments for major depression are also featured: one tested lurasidone treatment for major depressive disorder with mixed features, the other compared bitemporal ECT with high-dose unilateral ECT given twice a week.

Editorial Board

Editor-in-Chief
Robert Freedman, M.D.

Deputy Editors
David A. Lewis, M.D.
Robert Michels, M.D.
Daniel S. Pine, M.D.
Susan K. Schultz, M.D.
Carol A. Tamminga, M.D.

Associate Editors
Alan Brown, M.D., M.P.H.
Tyrone Cannon, Ph.D.
Benjamin G. Druss, M.D., M.P.H.
Graham J. Emslie, M.D.
Daniel C. Javitt, M.D.
Bankole Johnson, M.D.
Ellen Leibenluft, M.D.
Joan L. Luby, M.D.
Constantine G. Lyketsos, M.D., M.H.S.
Helen S. Mayberg, M.D., F.R.C.P.C.
Barbara Milrod, M.D.
Terrie E. Moffitt, Ph.D.
A. John Rush, M.D.
Anita Thapar, M.B.B.Ch., F.R.C.Psych., Ph.D., F.Med.Sci.
Mauricio Tohen, M.D., Dr.PH., M.B.A.
Eduard Vieta, M.D., Ph.D.
Katherine L. Wisner, M.D., M.S.
Xin Yu, M.D.

Editor Emeritus
Nancy C. Andreasen, M.D., Ph.D.

Former Editors
Amariah Brigham, M.D., 1844–1849
T. Romeyn Beck, M.D., 1849–1854
John P. Gray, M.D., 1854–1886
G. Alder Blumer, M.D., 1886–1894
Richard Dewey, M.D., 1894–1897
Henry M. Hurd, M.D., 1897–1904
Edward N. Brush, M.D., 1904–1931
Clarence B. Farrar, M.D., 1931–1965
Francis J. Braceland, M.D., 1965–1978
John C. Nemiah, M.D., 1978–1993

Robert Freedman, M.D., is Professor and Chair of Psychiatry at the University of Colorado. He is a graduate of Harvard Medical School and a member of the Institute of Medicine of the National Academies of Science. He was recently confirmed for membership into the Dana Alliance for Brain Initiatives, a nonprofit organization whose members are among the world's foremost authorities on neuroscientific research and clinical neurology topics.